LynnLeeMD

Pediatric Hematology & Oncology • Cincinnati, OH

Research Assistant Professor, Division of Oncology, Cincinnati Children's Hospital Medical Center

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
3333 Burnet Ave
MLC 7018
Cincinnati, OH 45229
Phone+1 513-803-8377

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2010 - 2013
Emory University School of MedicineClass of 2010

Certifications & Licensure

OH State Medical License 2010 - 2026
KY State Medical License 2021 - 2022
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukae...
Francis R LeBlanc, Erin H Breese, Karen C Burns, Ellen K Chang, LaQuita M Jones
British Journal of Haematology. 2024-09-01
25 citations
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.
Tomoya Muto, Maria Guillamot, Jennifer Yeung, Jing Fang, Joshua Bennett
Cell Stem Cell. 2022-02-03
3 citations
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective
Jeremy D. Rubinstein, Rachana Shah, Erin H. Breese, Karen Burns, Jennifer Mangino
Pediatric Blood & Cancer. 2021-05-21

Abstracts/Posters

V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia
Lynn Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity
Lynn Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019